read more

first_imgNews | September 09, 2014 Accuray Signs Exclusive Radiation Therapy Solutions Contract With Premier Inc. The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more Catalyst PT image courtesy of C-RAD News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more September 9, 2014 — Accuray Inc. announced it has been awarded a new exclusive three-year group purchasing agreement with Premier Inc., covering the CyberKnife M6 and TomoTherapy HDA product portfolios. The Accuray and Premier partnership brings together two companies committed to driving improved patient care through meaningful technical innovation.”Our goal is to help healthcare providers offer the best treatment option for their patients. The Premier agreement is important because it enables us to partner with a large sales force that has long-standing relationships with hospital-based clinicians and administrators to significantly increase visibility of the CyberKnife and TomoTherapy systems,” said Kelly Londy, executive vice president and chief commercial officer of Accuray.Premier has one of the nation’s largest group purchasing organizations (GPOs). Under the new contract, Accuray’s precise, clinically proven tumor treatments became available starting Sept. 1 to Premier member hospitals and providers. Premier unites an collective of more than 3,000 hospitals and 110,000 other providers, including oncology centers. In addition, the contract provides Accuray with access to key Premier integrated delivery network partners, where Accuray has had limited historical business presence.”We believe the Premier agreement will provide improved deal visibility to radiation equipment purchasing decisions earlier in the process and, ultimately, result in new opportunities for Accuray equipment and services,” said Joshua H. Levine, president and CEO of Accuray. “The partnership also validates our focus on service excellence and technology performance, and demonstrates the confidence the radiation oncology community has in the unique benefits of the CyberKnife and TomoTherapy Systems.”For more information: www.accuray.com FacebookTwitterLinkedInPrint分享 News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read more Related Content Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communicationslast_img read more

Read More